Giovannini M, Valsasina R, Longhi R, Cesura A M, Galva M D, Riva E, Bondiolotti G P, Picotti G B
5th Pediatric Department, University of Milan, Italy.
J Inherit Metab Dis. 1988;11(3):285-90. doi: 10.1007/BF01800371.
In three untreated patients with phenylketonuria (PKU), three PKU and six hyperphenylalaninaemic (HPA) patients in good metabolic control, the kinetic constants of platelet in vitro uptake of [14C]serotonin (5HT) did not significantly differ from those in 12 control subjects matched for age. The platelet concentrations of endogenous 5HT and noradrenaline (NA), taken as long-term indices of the amount of these amines circulating in plasma, were lower than normal in PKU and HPA patients, whether or not they were kept on a diet. However, a reduction in plasma NA concentrations at the moment of blood collection was seen only in untreated PKU patients. These data indicate that there may be a chronic inhibition of 5HT and possibly of NA synthesis even in PKU or HPA subjects in good metabolic control, with normal psychomotor development and only slightly raised plasma phenylalanine levels.
在3名未经治疗的苯丙酮尿症(PKU)患者、3名处于良好代谢控制状态的PKU患者以及6名高苯丙氨酸血症(HPA)患者中,血小板对[14C]血清素(5HT)的体外摄取动力学常数与12名年龄匹配的对照受试者相比无显著差异。作为血浆中这些胺类循环量长期指标的内源性5HT和去甲肾上腺素(NA)的血小板浓度,无论是否接受饮食治疗,PKU和HPA患者均低于正常水平。然而,仅在未经治疗的PKU患者中观察到采血时血浆NA浓度降低。这些数据表明,即使在代谢控制良好、精神运动发育正常且血浆苯丙氨酸水平仅略有升高的PKU或HPA受试者中,也可能存在对5HT以及可能对NA合成的慢性抑制。